K-ras mutations in müllerian inclusion cysts associated with serous borderline tumors of the ovary

Gynecologic Oncology

Volumn 80, Issue 2, 2001, Pages 201-206

  Alvarez, Angeles A ^a   Moore, William F ^b   Robboy, Stanley J ^a,b   Bentley, Rex C ^b   Gumbs, Curtis ^b   Futreal, P Andrew ^a,b   Berchuck, Andrew ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

K ras; M llerian inclusion cyst; Serous borderline ovarian tumor

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; PHOSPHORUS 32;

ADULT; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; CYST; DISEASE ASSOCIATION; DNA DETERMINATION; EXON; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HUMAN; HUMAN TISSUE; MUELLERIAN INCLUSION CYST; ONCOGENE K RAS; OVARY TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0035135494     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.6066     Document Type: Article

References (26)

1. Glandular inclusions in pelvic and abdominal para-aortic lymph nodes. A study of autopsy and surgical material in males and females
2. Frequency and histogenesis of pelvic retroperitoneal lymph node inclusions of the female genital tract. An immunohistochemical study of 34 cases
3. Neoplastic and non-neoplastic mesothelial proliferations in pelvic lymph nodes
4. Possible metaplastic origin of lymph node "metastases" in serous ovarian tumor of low malignant potential (borderline serous tumor)
5. Distinguishing lymph node metastases from benign glandular inclusions in low-grade ovarian carcinoma
6. Mullerian inclusion cysts-hypothesis that many are metastases associated with serous borderline tumors of the ovary
7. Tumor recurrence in stage I ovarian serous neoplasms of low malignant potential
8. Common epithelial tumors of borderline malignancy (carcinomas of low malignant potential)
9. Ovarian serous tumors of low malignant potential (serous borderline tumors). The relationship of exophytic surface tumor to peritoneal "implants"
10. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors
11. Non-invasive ovarian carcinoma
12. Peritoneum
13. p53 gene mutation in human borderline epithelial ovarian tumors
14. p53 gene analysis of ovarian borderline tumors and stage I carcinomas
15. Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors
16. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium
17. Duct changes and K-ras mutations in the disease-free pancreas: Analysis of type, age relation and spatial distribution
18. Multiple K-ras mutations in hyperplasia and carcinoma in cases of human pancreatic carcinoma
19. Ras oncogene p21 levels parallel malignant potential of different human colonic benign conditions
20. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms
21. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy
22. Comparison of mutations of Ki-RAS and p 53 immunoreactivity in borderline and malignant epithelial ovarian tumors
23. Ovarian, peritoneal, and endometrial serous carcinoma: Clonal origin of multifocal disease
24. Clonal origin of epithelial ovarian cancer: Analysis by loss of heterozygosity, p53 mutation and X-chromosome inactivation
25. Long-term follow-up of serous ovarian tumors of low malignant potential
26. Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (a Gynecologic Oncology Group study)